Corporation (NYSE: SUSS) announced today it has closed on a new $500 million
revolving credit facility with a variable interest rate initially set at LIBOR
plus 200 basis points.
Concurrently, the Company has notified the...
Analysts at Bank of America initiated coverage on shares of Sarepta Therapeutics (NASDAQ: SRPT) with an “outperform” rating. The target price range for Sarepta Therapeutics is set to $63. Sarepta Therapeutics' shares closed at $34.05...
In a report published Wednesday, BMO Capital Markets analyst Karen Short reiterated a Market Perform rating on Susser Holdings Corporation (NYSE: SUSS), and raised the price target from $45.00 to $55.00.
In the report, Short noted, “We...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Susser Holdings (SUSS):